INCY Incyte Corporation
Company Analysis
Latest News
🔴 Incyte Corporation is trading 4.4% down today after announcing a $2 billion acquisition of Vega Therapeutics
Incyte Corporation is trading 4.4% down at $96.22 after announcing a major acquisition of Vega Therapeutics for up to $2.0 billion, including $1.25 billion...
Incyte to Acquire Vega Therapeutics for up to $2.0 Billion, Expanding Hematology Portfolio
Incyte Corporation announced a definitive agreement to acquire Vega Therapeutics, Inc., a subsidiary of Star Therapeutics, for an upfront payment of $1.25...
Incyte Nears $2 Billion Star Therapeutics Deal, Targeting Bleeding Disorder Drug
Incyte is reportedly nearing a $2 billion acquisition of privately held Star Therapeutics. The agreement includes a $1.25 billion upfront cash payment....
🟢 Incyte Corporation is trading 4.4% up today as it extends a three-day rebound
Incyte Corporation is trading 4.4% up at $105.72 on momentum and dip-buying as the stock extends a three-day recovery from levels below $93. • The move...
🟢 Incyte Corporation is trading 4.4% up today, extending a three-day rebound despite broader market weakness
Incyte Corporation is trading 4.4% up at $105.67, extending a sharp three-day rebound from below $93 despite broader U.S. indices trading lower. • The move...